Anti-Inflammatory Effects of Novel Standardized Solid Lipid Curcumin Formulations

Journal of Medicinal Food

Volumn 18, Issue 7, 2015, Pages 786-792

  Nahar, Pragati P ^a   Slitt, Angela L ^a   Seeram, Navindra P ^a  

^a UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

curcumin; inflammation; interleukin 1 ; interleukin 6; Longvida ; NF B; nitric oxide; prostaglandin E2

Indexed keywords

CURCUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROSTAGLANDIN E2; SOLID LIPID CURCURMIN PARTICLE; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; AUTACOID; LIPID; WATER;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG CYTOTOXICITY; IN VITRO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOAVAILABILITY; CHEMISTRY; DRUG EFFECTS; MEDICINAL CHEMISTRY; RAW 264.7 CELL LINE; SOLUBILITY;

CURCUMA LONGA; MURINAE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CURCUMIN; DINOPROSTONE; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LIPIDS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE; RAW 264.7 CELLS; SOLUBILITY; WATER;

EID: 84933509691     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2014.0053     Document Type: Article

References (40)

1. Chen S: Natural products triggering biological targets - a review of the anti-inflammatory phytochemicals targeting the arachidonic acid pathway in allergy asthma and rheumatoid arthritis. Curr Drug Targets 2011;12:288-301.
2. Kim MK, Kim K, Han JY, Lim JM, Song YS: Modulation of inflammatory signaling pathways by phytochemicals in ovarian cancer. Genes Nutr 2011;6:109-115.
3. Ros E, Tapsell LC, Sabate J: Nuts and berries for heart health. Curr Atheroscler Rep 2010;12:397-406.
4. Tan AC, Konczak I, Sze DM, Ramzan I: Molecular pathways for cancer chemoprevention by dietary phytochemicals. Nutr Cancer 2011;63:495-505.
5. Tapsell LC, Hemphill I, Cobiac L, et al.: Health benefits of herbs and spices: the past, the present, the future. Med J Aust 2006;185(4 Suppl):S4-S24.
6. Zeng H, Lazarova DL: Obesity-related colon cancer: dietary factors and their mechanisms of anticancer action. Clin Exp Pharmacol Physiol 2012;39:161-167.
7. Zeilhofer HU, Brune K: Analgesic strategies beyond the inhibition of cyclooxygenases. Trends Pharmacol Sci 2006;27:467-474.
8. Yoon W-J, Ham YM, Kim S-S, et al.: Suppression of proinflammatory cytokines, iNOS, and COX-2 expression by brown algae Sargassum micracanthum in RAW 264.7 macrophages. Eur Asian J Biosci 2009;3:130-143.
9. Del Rio D, Borges G, Crozier A: Berry flavonoids and phenolics: bioavailability and evidence of protective effects. Br J Nutr 2010;104 Suppl 3:S67-S90.
10. Del Rio D, Costa LG, Lean ME, Crozier A: Polyphenols and health: what compounds are involved? Nutr Metab Cardiovasc Dis 2010;20:1-6.
11. Ammon HP, Wahl MA: Pharmacology of Curcuma longa. Planta Med 1991;57:1-7.
12. Bisht K, Choi WH, Park SY, Chung MK, Koh WS: Curcumin enhances non-inflammatory phagocytic activity of RAW264.7 cells. Biochem Biophys Res Commun 2009;379:632-636.
13. Aggarwal BB, Sung B: Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 2009;30:85-94.
14. Jagetia GC, Aggarwal BB: ''Spicing up'' of the immune system by curcumin. J Clin Immunol 2007;27:19-35.
15. Shishodia S, Sethi G, Aggarwal BB: Curcumin: getting back to the roots. Ann NY Acad Sci 2005;1056:206-217.
16. Olivera A, Moore TW, Hu F, et al.: Inhibition of the NF-kappaB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties. Int Immunopharmacol 2012;12:368-377.
17. Gao X, Kuo J, Jiang H, et al.: Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro. Biochem Pharmacol 2004;68:51-61.
18. Rasheed Z, Akhtar N, Anbazhagan AN, Ramamurthy S, Shukla M, Haqqi TM: polyphenol-rich pomegranate fruit extract (POMx) suppresses PMACI-induced expression of pro-inflammatory cytokines by inhibiting the activation of MAP Kinases and NF-kappaB in human KU812 cells. J Inflamm (Lond) 2009;6:1.
19. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB: Bioavailability of curcumin: problems and promises. Mol Pharm 2007;4:807-818.
20. Shehzad A, Wahid F, Lee YS: Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials. Arch Pharm (Weinheim) 2010;343:489-499.
21. Cheng AL, Hsu CH, Lin JK, et al.: Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 2001;21:2895-2900.
22. Anand P, Nair HB, Sung B, et al.: Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem Pharmacol 2010;79:330-338.
23. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS: Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 1998;64:353-356.
24. Bisht S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A: Polymeric nanoparticle-encapsulated curcumin (''nanocurcumin''): a novel strategy for human cancer therapy. J Nanobiotechnol 2007;5:3.
25. Gota VS, Maru GB, Soni TG, Gandhi TR, Kochar N, Agarwal MG: Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers. J Agric Food Chem 2010;58:2095-2099.
26. Dadhaniya P, Patel C, Muchhara J, et al.: Safety assessment of a solid lipid curcumin particle preparation: acute and subchronic toxicity studies. Food Chem Toxicol 2011;49:1834-1842.
27. DiSilvestro RA, Joseph E, Zhao S, Bomser J: Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people. Nutr J 2012;11:79.
28. Ma QL, Zuo X, Yang F, et al.: Curcumin suppresses soluble tau dimers and corrects molecular chaperone, synaptic, and behavioral deficits in aged human tau transgenic mice. J Biol Chem 2013;288:4056-4065.
29. Li L, Henry GE, Seeram NP: Identification and bioactivities of resveratrol oligomers and flavonoids from Carex folliculata seeds. J Agric Food Chem 2009;57:7282-7287.
30. Legault J, Girard-Lalancette K, Grenon C, Dussault C, Pichette A: Antioxidant activity, inhibition of nitric oxide overproduction, and in vitro antiproliferative effect of maple sap and syrup from Acer saccharum. J Med Food 2010;13:460-468.
31. Djoko B, Chiou RY, Shee JJ, Liu YW: Characterization of immunological activities of peanut stilbenoids, arachidin-1, piceatannol, and resveratrol on lipopolysaccharide-induced inflammation of RAW 264.7 macrophages. J Agric Food Chem 2007;55:2376-2383.
32. Kurien BT, Singh A, Matsumoto H, Scofield RH: Improving the solubility and pharmacological efficacy of curcumin by heat treatment. Assay Drug Dev Technol 2007;5:567-576.
33. Hevel JM, Marletta MA: Nitric-oxide synthase assays. Methods Enzymol 1994;233:250-258.
34. Karin M, Greten FR: NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005;5:749-759.
35. Lee H, Cho H, Lim D, Kang Y, Lee K, Park J: Mechanisms by which licochalcone E exhibits potent anti-inflammatory properties: studies with phorbol ester-treated mouse skin and lipopolysaccharide-stimulated murine macrophages. Int J Mol Sci 2013;14:10926-10943.
36. Karin M: NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol 2009;1:a000141.
37. Brouet I, Ohshima H: Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophys Res Commun 1995;206:533-540.
38. Pan MH, Lin-Shiau SY, Lin JK: Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages. Biochem Pharmacol 2000;60:1665-1676.
39. Zhao C, Yang J, Wang Y, et al.: Synthesis of mono-carbonyl analogues of curcumin and their effects on inhibition of cytokine release in LPS-stimulated RAW 264.7 macrophages. Bioorg Med Chem 2010;18:2388-2393.
40. Guimaraes MR, Leite FR, Spolidorio LC, Kirkwood KL, Rossa C, Jr.: Curcumin abrogates LPS-induced pro-inflammatory cytokines in RAW 264.7 macrophages. Evidence for novel mechanisms involving SOCS-1, -3 and p38 MAPK. Arch Oral Biol 2013;58:1309-1317.